![Adapt Pharma Clarifies Confusion Between NARCAN™ Nasal Spray and Injectable Naloxone Emergency Opioid Treatments Adapt Pharma Clarifies Confusion Between NARCAN™ Nasal Spray and Injectable Naloxone Emergency Opioid Treatments](https://mma.prnewswire.com/media/473554/Adapt_Pharma_Adapt_Pharma_Clarifies_Confusion_Between_NARCAN__Na.jpg?p=twitter)
Adapt Pharma Clarifies Confusion Between NARCAN™ Nasal Spray and Injectable Naloxone Emergency Opioid Treatments
![Naloxone nasal spray, sold under the brand name Narcan, is shown in 2016. Emergent Biosolutions will pay $735 million in cash and stock to acquire Adapt Pharma, the Dublin, Ireland-based maker of Naloxone nasal spray, sold under the brand name Narcan, is shown in 2016. Emergent Biosolutions will pay $735 million in cash and stock to acquire Adapt Pharma, the Dublin, Ireland-based maker of](https://c8.alamy.com/comp/2EWRME3/naloxone-nasal-spray-sold-under-the-brand-name-narcan-is-shown-in-2016-emergent-biosolutions-will-pay-735-million-in-cash-and-stock-to-acquire-adapt-pharma-the-dublin-ireland-based-maker-of-narcan-photo-by-terrence-antonio-jameschicago-tribunetnssipa-usa-2EWRME3.jpg)
Naloxone nasal spray, sold under the brand name Narcan, is shown in 2016. Emergent Biosolutions will pay $735 million in cash and stock to acquire Adapt Pharma, the Dublin, Ireland-based maker of
![Adapt Pharma Clarifies Confusion Between NARCAN™ Nasal Spray and Injectable Naloxone Emergency Opioid Treatments Adapt Pharma Clarifies Confusion Between NARCAN™ Nasal Spray and Injectable Naloxone Emergency Opioid Treatments](https://mma.prnewswire.com/media/473554/Adapt_Pharma_Adapt_Pharma_Clarifies_Confusion_Between_NARCAN__Na.jpg?p=facebook)